GLP-1 News
A Weekly Newsletter Tracking the Latest in GLP-1 Drugs, Research, and Real-World Impact
New research indicates that semaglutide drugs like Ozempic may lower the risk of early-onset colorectal cancer in diabetes patients under 50.
